FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098318 [Registered on: 02/12/2025] Trial Registered Prospectively
Last Modified On: 20/10/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study to see how homoeopathic medicines help in reducing knee pain and improving movement in older adults with knee osteoarthritis compared with dummy treatment (placebo) 
Scientific Title of Study   Effectiveness of homoeopathic palliative management in knee osteoarthritis among geriatric age group-a placebo controlled experimental study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhawna Haridas Bodele 
Designation  PHD SCHOLAR 
Affiliation  Dr G.D Pol Foundation Y.M.T Homoeopathic Medical College and Hospital (Post Graduate Institute) 
Address  Dr G.D Pol Foundation Y.M.T. HOMOEOPATHIC MEDICAL COLLEGE-HOSPITAL (POST-GRADUATE INSTITUTE) Fourth floor, Department of Practice of Medicine Institutional Area,sector-4,Kharghar,Navi Mumbai 410210

Mumbai
MAHARASHTRA
410210
India 
Phone  9766914576  
Fax    
Email  bhawnabodele123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sachin Chokakkar  
Designation  Associate Professor of Practice of Medicine Department 
Affiliation  Dr G.D Pol Foundation Y.M.T Homoeopathic Medical College and Hospital (Post Graduate Institute) 
Address  Dr G.D Pol Foundation Y.M.T. HOMOEOPATHIC MEDICAL COLLEGE-HOSPITAL (POST-GRADUATE INSTITUTE) Fourth floor, Department of Practice of Medicine Institutional Area,sector-4,Kharghar,Navi Mumbai 410210

Mumbai
MAHARASHTRA
410210
India 
Phone  9172488888  
Fax    
Email  newbeginingsach@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhawna Haridas Bodele 
Designation  PHD SCHOLAR 
Affiliation  Dr G.D Pol Foundation Y.M.T Homoeopathic Medical College and Hospital (Post Graduate Institute) 
Address  Dr G.D Pol Foundation Y.M.T. HOMOEOPATHIC MEDICAL COLLEGE-HOSPITAL (POST-GRADUATE INSTITUTE) Fourth floor, Department of Practice of Medicine Institutional Area,sector-4,Kharghar,Navi Mumbai 410210

Mumbai
MAHARASHTRA
410210
India 
Phone  09766914576  
Fax    
Email  bhawnabodele123@gmail.com  
 
Source of Monetary or Material Support  
Dr G.D Pol Foundation YMT Homoeopathic Medical College and Hospital(Post Graduate Institute) Institutional Area,sector-4,Kharghar,Navi Mumbai Maharashtra 410210 India 
 
Primary Sponsor  
Name  DR GD POL FOUNDATION YMT HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL POST GRADUATE INSTITUTE 
Address  DR G.D POL FOUNDATION Y.M.T. HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL (POST-GRADUATE INSTITUTE) Institutional Area,sector-4,Kharghar,Navi Mumbai Maharashtra 410210 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhawna Haridas Bodele  Y.M.T Homoeopathic Medical College and Hospital (Post Graduate Institute)  Fourth floor, Department of Practice of Medicine Institutional Area,sector-4,Kharghar,Navi Mumbai Maharashtra 410210
Mumbai
MAHARASHTRA 
09766914576

bhawnabodele123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr G.D Pol Foundation Y.M.T Homoeopathic Medical College and Hospital (Post Graduate Institute)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic palliative management with standard auxiliary measures such as mesmerism,massage,bath,health education,exercise therapy,physiotherapy.   Dose of Homoeopathic medicine would be chosen on patient susceptibility, follow up-Every 15 days If required Homoeopathic medicine will be repeated or placebo will be given, Route of administration of medicine would be oral route, duration of medicine would be one year  
Comparator Agent  Homoeopathic placebo with with standard auxiliary measures such as mesmerism,massage,bath,health education,exercise therapy,physiotherapy.   Homoeopathic placebo would be given daily, oral route of administration, duration is for one year  
 
Inclusion Criteria  
Age From  65.00 Year(s)
Age To  95.00 Year(s)
Gender  Both 
Details  1. Clinically diagnosed patients of unilateral or bilateral knee osteoarthritis.
2. Patients of all genders.
3. Patients of age group 65 years and above.
4. Patients with or without comorbidities.
5. Patients should have history of symptomatic knee osteoarthritis for at least 6 months. 
 
ExclusionCriteria 
Details  1. Non ambulatory patient.
2. Patient with suspected immune compromised condition.
3. Recent surgical intervention performed on knee joint within 12 months.
4.Patients with organ failure
5.Patients on any other medication of knee osteoarthritis 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Homoeopathic palliative management is effective as compare to placebo in knee osteoarthritis among geriatric age group
 
Time points of WOMAC SCALE application will be 0 months,4 months,8 months,12 months 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate pre and post outcome of WOMAC scale as compare as compare to placebo in knee osteoarthritis among geriatric age group  Time points of WOMAC SCALE application will be 0 months,4 months,8 months,12 months 
To identify the geriatric age group that demonstrate the highest improvement in knee osteoarthritis as measure by WOMAC scale
To identify the common group of Homoeopathic remedies indicated in
palliative management of knee Osteoarthritis in geriatric patients 
Time points of WOMAC SCALE application will be 0 months,4 months,8 months,12 months 
 
Target Sample Size   Total Sample Size="94"
Sample Size from India="94" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Osteoarthritis (OA) is by far the most common form of arthritis and is a major cause of pain and disability in older people. It is characterized by focal loss of articular cartilage, subchondral osteosclerosis, osteophyte formation at the joint margin and remodeling of joint contour with enlargement of affected joints. 
Clinical features -
Symptoms:-
1. Pain:
a. Insidious onset over months or years.
b. Variable or intermittent overtime.(good days,bad days)
c. Mainly related to movement and weight-bearing, relived by rest.
d. Only brief (<15minuts) morning stiffness and brief (<1minute) gelling
after rest.
e. Usually only one or few joints painful
Signs: -
a. Restricted movement (Capsular thickening, blocking by osteophyte).
b. Palpable, sometimes audible coarse crepitus (rough articular surfaces).
c. Bony swelling around right joint margins
d.Deformity,usually without instability.
e.Joint-line or periarticular tenderness.
f.Muscle weakness, wasting.
g.Mild or absent synovitis 
Etiology:
Classification of knee OA is divided into primary and secondary,depending on the cause. Primary knee OA results from articular cartilage degeneration,the exact cause of which is still unknown, presumably due to increasing age. Secondary knee OA results from articular cartilage degeneration with known causes, including post-traumatic,congenital, or limb malformations,malposition (varus/valgus), scoliosis, rachitis, Wilson’s disease, gout,pseudogout, rheumatoid arthritis, hemophilia, and Paget’s disease.
Risk Factors of Knee osteoarthritis :
Modifiable
a. Articular trauma
b.Occupation – prolonged standing and repetitive knee bending
c.Muscle weakness or imbalance
d.Weight
e.Health – metabolic syndrome
Non-modifiable
a.Gender - females more common than males
b.Age
c.Genetics
d.Race
Epidemiology:Depending on the source, roughly 13% of women and 10% of men 60 years and older have symptomatic knee osteoarthritis. Among those older than 70 years of age, the prevalence rises to as high as 40%.The prevalence of knee osteoarthritis in males is also lower than in females.
Study design- Single blind randomized placebo-controlled experimental study.
Study setting -Patient from Institute/Research centre OPD.
Study population-Patient from geriatric age group 65 years and above suffering from Knee Osteoarthritis from Institute/Research centre OPD
Methods of selection of study subjects
I.Inclusion criteria:
1. Clinically diagnosed patients of unilateral or bilateral knee osteoarthritis.
2. Patients of all genders.
3. Patients of age group 65 years and above. 
4. Patients with or without comorbidities.
5. Patients should have history of symptomatic knee osteoarthritis for at least 6 months.
II.Exclusion criteria:
1. Non ambulatory patient.
2. Patient with suspected immune compromised condition.
3. Recent surgical intervention performed on knee joint within 12 months.
4.Patients with organ failure
5.Patients on any other medication of knee
III.Patient withdrawl criteria
1. Patients not coming for regular follow up.
2. Patients who withdraw their consent from the study.
3. Medical and surgical emergency intervention during study.
4. If the WOMAC scale score doesn’t improve in 4 months of treatment.
Sampling technique- Simple random sampling based on inclusion and exclusion criteria.
Data collection methods-
1.Written Informed Consent will be taken in patient local vernacular language and also approved by Institutional Ethical committee
2. The detailed homoeopathic case-taking will be carried out.
3. Appropriate reference book like Homoeopathic Materia Medica, Medicine books, Rheumatology books, Pathology books, different Homoeopathic journals, research paper will be considered.
4. Appropriate software will be used for reportorization of case
Data collection instrument-
1. Written Informed Consent Form.
2. Standardized Case Record.
3.WOMAC scale scores 
Statistical analysis-Data collected will be compiled on to a MS Office excel worksheet & will be subjected to statistical analysis using an appropriate package like SPSS software. Descriptive statistics like frequency (n) & percentage (%) of categorical data,mean & Standard deviation of numerical data in each group / subgroup will be depicted.Frequency (n)& percentage (%) of various categories in each group/Subgroup will be compared using chi square test. Normality of numerical data will be checked using Shapiro – Wilk test or Kolmogorov-Smirnov test. Depending on the normality of data, statistical tests will be determined.For a numerical continuous data following a normal distribution, inter group comparison (2 groups) will be done using t test, else a non-parametric substitute like Mann Whitney U test will be used. Intra group comparisons for a numerical continuous data following a normal distribution will be done using paired t test (for 2 observations) or repeated measures ANOVA for >2 observations, else a non-parametric substitute like Wilcoxon signed rank test (for 2 observations) or Friedman’s test for >2 observations will be used. Frequency (n) & percentage (%) of various responses in each time interval will be compared using chi square test / Mc Nemar’s test. Keeping alpha error at 5% and Beta error at 20%, power at 80%, p< 0.05 will be considered statistically significant.
 
Close